Izguba teže je povezana z zmanjšanim tveganjem za polipe debelega črevesa in danke

Deli to objavo

Lahko 2022: According to study findings published February 1 in the Journal of the National Cancer Institute, overweight or obese adults who lose more than 5 pounds over five years have a 46 percent lower risk of developing precancerous colon polyps, which are benign growths in the colon or rectum that can lead to colorectal cancer.

Telesna teža in rak debelega črevesa

From 1993 to 2001, researchers examined the relationship between weight change and colon and rectal polyps in 18,588 men and women who took part in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening study. People who have self-reported their weight three times during the course of their lives were included in the study. The case group included 1,053 people who acquired polyps three to five years into the study, while the control group included those who did not. Those who dropped weight throughout early to late adulthood had a much lower risk of having polyps than those who maintained their weight, especially if they were initially overweight (had a BMI of more than 25). People who gained weight during the trial, on the other hand, had a 1.3 times higher risk of getting polyps. In comparison to women, the link appeared to be stronger in men.

Researchers have discovered for the first time that limiting weight gain during adulthood lowers the risk of acquiring precancerous growths that can lead to kolorektalnega raka. The advantages appear to be linked to being overweight or obese.

Naročite se na naše e-novice

Pridobite posodobitve in nikoli ne zamudite bloga Cancerfax

Več V Razišči

Človeška CAR T celična terapija: preboji in izzivi
CAR T-celična terapija

CAR T celična terapija na osnovi človeka: preboji in izzivi

Terapija T-celic CAR, ki temelji na ljudeh, spremeni zdravljenje raka z genetskim spreminjanjem bolnikovih lastnih imunskih celic za ciljanje in uničenje rakavih celic. Z izkoriščanjem moči imunskega sistema telesa te terapije ponujajo močno in osebno prilagojeno zdravljenje s potencialom za dolgotrajno remisijo pri različnih vrstah raka.

Razumevanje sindroma sproščanja citokinov: vzroki, simptomi in zdravljenje
CAR T-celična terapija

Razumevanje sindroma sproščanja citokinov: vzroki, simptomi in zdravljenje

Sindrom sproščanja citokinov (CRS) je reakcija imunskega sistema, ki jo pogosto sprožijo nekatera zdravljenja, kot je imunoterapija ali zdravljenje s celicami CAR-T. Vključuje prekomerno sproščanje citokinov, kar povzroča simptome, od vročine in utrujenosti do potencialno smrtno nevarnih zapletov, kot je poškodba organov. Upravljanje zahteva skrbno spremljanje in intervencijske strategije.

Rabim pomoč? Naša ekipa vam je pripravljena pomagati.

Želimo vam hitro okrevanje vašega dragega in bližnjega.

Začni klepet
Smo na spletu! Klepetajte z nami!
Skenirajte kodo
Zdravo,

Dobrodošli na CancerFax!

CancerFax je pionirska platforma, namenjena povezovanju posameznikov, ki se soočajo z napredovalim stadijem raka, z revolucionarnimi celičnimi terapijami, kot je CAR T-Cell terapija, TIL terapija in kliničnimi preskušanji po vsem svetu.

Sporočite nam, kaj lahko storimo za vas.

1) Zdravljenje raka v tujini?
2) CAR T-celična terapija
3) Cepivo proti raku
4) Spletno video posvetovanje
5) Protonska terapija